Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Establishment of a mammary carcinoma cell line from Syrian hamsters treated with N-methyl-N-nitrosourea.

Coburn MA, Brueggemann S, Bhatia S, Cheng B, Li BD, Li XL, Luraguiz N, Maxuitenko YY, Orchard EA, Zhang S, Stoff-Khalili MA, Mathis JM, Kleiner-Hancock HE.

Cancer Lett. 2011 Dec 15;312(1):82-90. doi: 10.1016/j.canlet.2011.08.003. Epub 2011 Aug 17.

2.

Expression of the vascular endothelial growth factor receptor neuropilin-1 in the human endometrium.

Hess AP, Schanz A, Baston-Buest DM, Hirchenhain J, Stoff-Khalili MA, Bielfeld P, Kruessel JS.

J Reprod Immunol. 2009 Jan;79(2):129-36. doi: 10.1016/j.jri.2008.09.001. Epub 2008 Nov 8. Erratum in: J Reprod Immunol. 2009 Jul;81(1):103.

PMID:
18996601
3.

Promotion of incisional wound repair by human mesenchymal stem cell transplantation.

Stoff A, Rivera AA, Sanjib Banerjee N, Moore ST, Michael Numnum T, Espinosa-de-Los-Monteros A, Richter DF, Siegal GP, Chow LT, Feldman D, Vasconez LO, Michael Mathis J, Stoff-Khalili MA, Curiel DT.

Exp Dermatol. 2009 Apr;18(4):362-9. doi: 10.1111/j.1600-0625.2008.00792.x. Epub 2008 Sep 18.

4.

Characterization of infectivity of knob-modified adenoviral vectors in glioma.

Paul CP, Everts M, Glasgow JN, Dent P, Fisher PB, Ulasov IV, Lesniak MS, Stoff-Khalili MA, Roth JC, Preuss MA, Dirven CM, Lamfers ML, Siegal GP, Zhu ZB, Curiel DT.

Cancer Biol Ther. 2008 May;7(5):786-93.

PMID:
18756624
5.

Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach.

Matthews QL, Yang P, Wu Q, Belousova N, Rivera AA, Stoff-Khalili MA, Waehler R, Hsu HC, Li Z, Li J, Mountz JD, Wu H, Curiel DT.

Virol J. 2008 Aug 21;5:98. doi: 10.1186/1743-422X-5-98.

6.

Enhanced Gene Delivery to Human Primary Endothelial Cells Using Tropism-Modified Adenovirus Vectors.

Preuss MA, Glasgow JN, Everts M, Stoff-Khalili MA, Wu H, Curiel DT.

Open Gene Ther J. 2008 Jan 1;1:7-11.

7.

Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control.

Stoff-Khalili MA, Rivera AA, Nedeljkovic-Kurepa A, DeBenedetti A, Li XL, Odaka Y, Podduturi J, Sibley DA, Siegal GP, Stoff A, Young S, Zhu ZB, Curiel DT, Mathis JM.

Breast Cancer Res Treat. 2008 Mar;108(1):43-55. Epub 2007 May 17.

8.

Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma.

Stoff-Khalili MA, Rivera AA, Mathis JM, Banerjee NS, Moon AS, Hess A, Rocconi RP, Numnum TM, Everts M, Chow LT, Douglas JT, Siegal GP, Zhu ZB, Bender HG, Dall P, Stoff A, Pereboeva L, Curiel DT.

Breast Cancer Res Treat. 2007 Oct;105(2):157-67. Epub 2007 Jan 13.

PMID:
17221158
9.

Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds.

Stoff A, Rivera AA, Mathis JM, Moore ST, Banerjee NS, Everts M, Espinosa-de-los-Monteros A, Novak Z, Vasconez LO, Broker TR, Richter DF, Feldman D, Siegal GP, Stoff-Khalili MA, Curiel DT.

J Mol Med (Berl). 2007 May;85(5):481-96. Epub 2007 Jan 12.

PMID:
17219096
10.

Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion.

Matthews QL, Sibley DA, Wu H, Li J, Stoff-Khalili MA, Waehler R, Mathis JM, Curiel DT.

Mol Imaging. 2006 Oct-Dec;5(4):510-9. Erratum in: Mol Imaging. 2007 Jan-Feb;6(1):72.

11.

Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer.

Stoff-Khalili MA, Rivera AA, Stoff A, Michael Mathis J, Rocconi RP, Matthews QL, Numnum MT, Herrmann I, Dall P, Eckhoff DE, Douglas JT, Siegal GP, Zhu ZB, Curiel DT.

Int J Cancer. 2007 Feb 15;120(4):935-41.

12.

Targeting lung cancer using an infectivity enhanced CXCR4-CRAd.

Zhu ZB, Rivera AA, Makhija SK, Lu B, Wang M, Izumi M, Cerfolio RJ, Stoff-Khalili MA, Zhou F, Takayama K, Siegal GP, Curiel DT.

Lung Cancer. 2007 Feb;55(2):145-56. Epub 2006 Nov 17.

13.

[Commentary on the work of F.K. Beller. The antagonistic attitude towards gynecology and obstetrics between the United States and Germany].

Stoff-Khalili MA, Bender HG.

Zentralbl Gynakol. 2006 Oct;128(5):275-6. German. No abstract available.

PMID:
17061397
14.

Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds.

Stoff A, Rivera AA, Banerjee NS, Mathis JM, Espinosa-de-los-Monteros A, Le LP, De la Torre JI, Vasconez LO, Broker TR, Richter DF, Stoff-Khalili MA, Curiel DT.

Wound Repair Regen. 2006 Sep-Oct;14(5):608-17.

15.

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses.

Komarova S, Kawakami Y, Stoff-Khalili MA, Curiel DT, Pereboeva L.

Mol Cancer Ther. 2006 Mar;5(3):755-66.

16.

Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system.

Stoff-Khalili MA, Stoff A, Rivera AA, Banerjee NS, Everts M, Young S, Siegal GP, Richter DF, Wang M, Dall P, Mathis JM, Zhu ZB, Curiel DT.

Breast Cancer Res. 2005;7(6):R1141-52. Epub 2005 Nov 16.

17.

Gene therapy for carcinoma of the breast.

Stoff-Khalili MA, Dall P, Curiel DT.

Cancer Gene Ther. 2006 Jul;13(7):633-47. Epub 2006 Jan 6. Review.

18.

Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents.

Stoff-Khalili MA, Rivera AA, Le LP, Stoff A, Everts M, Contreras JL, Chen D, Teng L, Rots MG, Haisma HJ, Rocconi RP, Bauerschmitz GJ, Rein DT, Yamamoto M, Siegal GP, Dall P, Michael Mathis J, Curiel DT.

Cancer Gene Ther. 2006 Jun;13(6):606-18.

PMID:
16410819
19.

Oncolytic adenoviruses - selective retargeting to tumor cells.

Mathis JM, Stoff-Khalili MA, Curiel DT.

Oncogene. 2005 Nov 21;24(52):7775-91. Review.

PMID:
16299537
20.

Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system.

Stoff-Khalili MA, Stoff A, Rivera AA, Mathis JM, Everts M, Wang M, Kawakami Y, Waehler R, Mathews QL, Yamamoto M, Rocconi RP, Siegal GP, Richter DF, Dall P, Zhu ZB, Curiel DT.

Cancer Biol Ther. 2005 Nov;4(11):1203-10. Epub 2005 Nov 8.

PMID:
16177567
21.

A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.

Stoff-Khalili MA, Rivera AA, Glasgow JN, Le LP, Stoff A, Everts M, Tsuruta Y, Kawakami Y, Bauerschmitz GJ, Mathis JM, Pereboeva L, Seigal GP, Dall P, Curiel DT.

Gene Ther. 2005 Dec;12(23):1696-706.

PMID:
16034451
22.

From gene therapy to virotherapy for ovarian cancer.

Stoff-Khalili MA, Dall P, Curiel DT.

Minerva Ginecol. 2004 Dec;56(6):503-14. Review.

PMID:
15729203
23.

In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cells.

Dall P, Herrmann I, Durst B, Stoff-Khalili MA, Bauerschmitz G, Hanstein B, Niederacher D.

Cancer Immunol Immunother. 2005 Jan;54(1):51-60.

PMID:
15693139
24.

Subfascial periareolar augmentation mammaplasty.

Stoff-Khalili MA, Scholze R, Morgan WR, Metcalf JD.

Plast Reconstr Surg. 2004 Oct;114(5):1280-8; discussion 1289-91.

PMID:
15457050

Supplemental Content

Loading ...
Support Center